Introduction: Who Needs Brain Tumor Diagnostics and When to Seek Help

Not everyone who experiences a headache or feels dizzy needs to worry about a brain tumor, but certain warning signs should never be ignored. A malignant brain tumor, also called a brain cancer, is a cancerous growth of cells inside or near the brain that grows quickly and can invade healthy brain tissue. Understanding when to seek medical attention can make a significant difference in the outcome of treatment.^[1]

People should consider consulting a doctor if they experience persistent or worsening symptoms that don’t have an obvious explanation. These symptoms can vary widely depending on where the tumor is located in the brain and how fast it’s growing. Some tumors cause symptoms right away because they develop in active areas of the brain, while others can grow quite large before being noticed if they’re in less active regions.^[1]

Common warning signs that warrant medical evaluation include ongoing severe headaches that may worsen in the morning or with physical activity, seizures or convulsions that occur for the first time, persistent nausea and vomiting especially upon waking, and unexplained weakness or numbness on one side of the body. Vision changes such as blurry or double vision, difficulty with balance or coordination, confusion or memory problems, personality changes, and trouble speaking or understanding others are also concerning symptoms.^[2][3]

Malignant brain tumors can affect people of any age, though they’re more common in adults, especially those over 60 years old. Different types of brain tumors have varying age patterns. For instance, glioblastomas, which are the fastest-growing and most common malignant brain tumors, appear more often in older adults. However, other brain tumor types can occur in children and young adults, meaning no age group is entirely immune.^[2]

The diversity of symptoms and their relationship to the tumor’s location in the brain makes diagnosis challenging. The brain controls different functions in different areas, so a tumor in the frontal lobe might cause personality changes and difficulty with movement, while a tumor in the temporal lobe might affect memory and hearing. A tumor near the visual processing areas might cause vision problems. This is why a thorough diagnostic process is essential to pinpoint not just the presence of a tumor, but its exact location and characteristics.^[2]

Classic Diagnostic Methods for Identifying Malignant Brain Tumors

When a person presents with symptoms that suggest a possible brain tumor, doctors follow a systematic approach to diagnosis. This process typically begins with the least invasive tests and progresses to more detailed examinations as needed. Each test provides different information that helps build a complete picture of what’s happening inside the brain.^[8]

Neurological Examination

The diagnostic journey usually starts with a neurological exam, which is a series of tests that assess how well different parts of the brain are functioning. During this examination, a doctor checks various aspects of brain and nervous system function including vision, hearing, balance, coordination, strength, and reflexes. The doctor may also test the patient’s ability to feel sensations, their memory, and their ability to perform simple tasks.^[8]

If a patient has trouble in one or more areas during the neurological exam, this provides important clues about which part of the brain might be affected. For example, weakness on one side of the body suggests a problem on the opposite side of the brain, since the brain’s control pathways cross over. While a neurological exam doesn’t detect a brain tumor directly, it helps the doctor understand what part of the brain might be causing the symptoms and guides decisions about what imaging tests to order next.^[8]

Computed Tomography Scan

A CT scan, or computed tomography scan, uses X-rays to create detailed pictures of the inside of the head. This imaging test is widely available and results come back quickly, making it often the first imaging test performed when someone has symptoms like severe headaches or neurological problems. The CT scan can detect abnormalities in and around the brain, showing if there’s a mass, swelling, or bleeding.^[8]

The results of a CT scan give the healthcare team important initial clues. If the CT scan shows something suspicious that looks like a brain tumor, the next step is usually to perform a brain MRI, which provides more detailed images. CT scans are particularly useful in emergency situations because they can be done quickly and help doctors decide if immediate action is needed.^[8]

Magnetic Resonance Imaging

MRI, or magnetic resonance imaging, uses strong magnets and radio waves to create very detailed pictures of the brain. MRI is particularly good at showing the difference between normal brain tissue and abnormal growths, making it one of the most important tools for detecting brain tumors. The images from an MRI show the brain more clearly than other imaging tests, allowing doctors to see smaller tumors and get a better sense of the tumor’s exact location and size.^[8]

During a brain MRI for tumor diagnosis, patients often receive an injection of a special dye called a contrast agent into a vein in the arm. This dye makes certain details show up more clearly on the images and makes it easier to see smaller tumors. The contrast also helps doctors distinguish between a brain tumor and healthy brain tissue, which is crucial for planning treatment. Some patients may need special types of MRI that provide additional information about how blood flows through the tumor or how the tumor is affecting nearby brain structures.^[8]

Biopsy Procedures

While imaging tests can show that an abnormal growth is present in the brain, they cannot definitively determine whether it’s cancerous or what specific type of tumor it is. For that information, doctors need to examine actual tumor cells under a microscope, which requires obtaining a tissue sample through a procedure called a biopsy. The biopsy is the only way to confirm a diagnosis of malignant brain tumor and identify its specific type.^[8]

There are different ways to obtain a biopsy sample. In some cases, a small sample of the tumor is removed through a procedure called a needle biopsy, where a thin needle is carefully inserted through a small hole in the skull to reach the tumor. The doctor uses imaging technology to guide the needle to exactly the right spot. In other cases, the biopsy is obtained during surgery to remove the tumor. When the surgeon removes part or all of the tumor, that tissue is sent to a laboratory where specialists examine it to determine the tumor type and grade.^[8]

The laboratory analysis of the biopsy sample involves examining the cells under a microscope to look at their structure and behavior. Pathologists, who are doctors specially trained in diagnosing diseases by examining tissues, can identify what type of cells the tumor is made from and how aggressive it appears. This information is critical because different types of brain tumors require different treatments. The pathology report from the biopsy helps doctors develop the most appropriate treatment plan for each individual patient.^[12]

Additional Imaging Studies

Beyond CT and MRI scans, doctors may use other imaging techniques to gather more information about a brain tumor. Nuclear scans, including PET scans (positron emission tomography), can show how active the tumor cells are by measuring their use of sugar or other substances. More active cells, which are often more aggressive cancer cells, show up more brightly on these scans. This information can help doctors understand how aggressive the tumor is and whether treatment is working.^[13]

Sometimes doctors order imaging of other parts of the body to determine whether a brain tumor started in the brain or spread there from cancer somewhere else. Brain tumors that originate in the brain are called primary brain tumors, while those that spread to the brain from other organs are called secondary or metastatic brain tumors. Knowing which type a patient has is important because it affects treatment decisions. If cancer is found elsewhere in the body, it suggests the brain tumor is metastatic rather than primary.^[1]

Diagnostics for Clinical Trial Qualification

When patients with malignant brain tumors consider participating in clinical trials, they typically need to undergo additional or more specific diagnostic testing. Clinical trials are research studies that test new treatments, and they have strict requirements about which patients can participate. These requirements, called eligibility criteria, often depend on specific characteristics of the patient’s tumor that can only be determined through detailed testing.^[12]

Molecular and Genetic Testing

Modern understanding of brain tumors has revealed that malignant brain tumors differ from each other not just in how they look under a microscope, but also in their genetic and molecular characteristics. These characteristics are like a fingerprint that can help predict how the tumor will behave and how it might respond to different treatments. Clinical trials often require patients to have tumors with specific molecular features, making genetic testing an important part of the qualification process.^[12]

When tumor tissue is obtained through biopsy or surgery, specialized laboratories can analyze it to look for specific genetic changes or mutations. For glioblastomas and other types of malignant brain tumors, doctors now routinely test for several key genetic markers. These include changes in genes called IDH (isocitrate dehydrogenase), EGFR (epidermal growth factor receptor), and TERT, among others. The presence or absence of these genetic changes helps classify the tumor more precisely and determines which clinical trials the patient might be eligible for.^[12]

Some clinical trials are specifically designed to test treatments that target tumors with certain genetic changes. For example, a trial might test a new drug that only works against tumors with a specific mutation. In such cases, patients must have genetic testing of their tumor tissue to confirm they have the required mutation before they can join the trial. This type of precision matching between tumor characteristics and treatment is becoming increasingly common in brain cancer research.^[12]

Performance Status Assessment

Clinical trials need to ensure that patients are healthy enough to tolerate the experimental treatment being studied. To measure this, doctors assess what’s called performance status, which is a standard way of describing how well a patient can perform daily activities and how much the disease is affecting their functioning. This assessment is typically required before a patient can enter a clinical trial.^[13]

Performance status is usually rated on a standardized scale. Doctors evaluate factors such as whether the patient can work, whether they need assistance with daily activities, and how much time they spend in bed during the day. A patient who is very active and can perform all normal activities without restrictions has a high performance status, while someone who requires significant assistance or is bedridden has a low performance status. Most clinical trials require patients to have a certain minimum performance status to participate, as this helps ensure they can safely complete the study.^[13]

Baseline Imaging and Measurements

Before starting a clinical trial, patients typically need detailed baseline imaging studies that will serve as a comparison point to measure whether the experimental treatment is working. These baseline scans must be done using specific techniques and following standardized procedures to ensure measurements are accurate and comparable over time. The imaging protocol for clinical trials may be more detailed than routine clinical imaging.^[13]

Doctors measure the tumor’s size carefully on these baseline scans and document its exact location and characteristics. During the trial, repeat imaging is performed at scheduled intervals, and the tumor is measured again using the same techniques. By comparing the new images to the baseline, doctors can determine if the tumor is shrinking, staying the same size, or growing. These measurements are crucial for determining whether the experimental treatment is effective.^[13]

Laboratory Testing

Clinical trials typically require extensive laboratory testing to ensure patients are healthy enough to participate and to monitor for potential side effects during the trial. Blood tests check the function of major organs including the kidneys, liver, and bone marrow. These organs need to be working well enough to process the experimental treatment and to tolerate any potential side effects.^[13]

Complete blood counts measure red blood cells, white blood cells, and platelets. Blood chemistry panels check kidney and liver function, electrolyte levels, and other important markers. Some trials also require testing for specific substances in the blood that might indicate how the tumor is behaving or how the patient’s body is responding to treatment. All of these baseline measurements are repeated during the trial to track changes and watch for problems.^[13]